Glimm Ekkehard
Novartis Pharma AG, Novartis Campus, Basel, Switzerland.
Otto-von-Guericke University, Institute of Biometry and Medical Informatics, Magdeburg, Germany.
Biom J. 2019 Jan;61(1):216-229. doi: 10.1002/bimj.201800097. Epub 2018 Nov 25.
This paper discusses a number of methods for adjusting treatment effect estimates in clinical trials where differential effects in several subpopulations are suspected. In such situations, the estimates from the most extreme subpopulation are often overinterpreted. The paper focusses on the construction of simultaneous confidence intervals intended to provide a more realistic assessment regarding the uncertainty around these extreme results. The methods from simultaneous inference are compared with shrinkage estimates arising from Bayesian hierarchical models by discussing salient features of both approaches in a typical application.
本文讨论了一些在怀疑几个亚组存在差异效应的临床试验中调整治疗效果估计值的方法。在这种情况下,来自最极端亚组的估计值往往被过度解读。本文重点关注同时置信区间的构建,旨在对这些极端结果周围的不确定性提供更实际的评估。通过在一个典型应用中讨论这两种方法的显著特征,将同时推断方法与贝叶斯分层模型产生的收缩估计值进行了比较。